Substance-Related Disorders Clinical Trial
Official title:
Parents as Interventionists for Moderate Drug Abusing Adolescents
Verified date | March 2023 |
Source | Public Health Management Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This project is aimed at parents with a teenager who is already starting to use drugs. The study will test a new, innovative version of a brief intervention. This program will be home based rather than implemented by a counselor in a clinical setting. The stage I activities will involve manual development, parent training development, and a small feasibility study; Stage II involves an efficacy study. Two samples, 110 families each, will participate in the trial. Families will be assigned to either an intervention or control condition. The investigators hypothesize that the home-based intervention will be superior to the control condition. In addition, the investigators expect response to the intervention by the adolescent to be mediated by motivation, cognitions, problem solving, peer drug use, parenting skills and parent self-efficacy.
Status | Completed |
Enrollment | 286 |
Est. completion date | April 2016 |
Est. primary completion date | April 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 19 Years |
Eligibility | Inclusion Criteria: 1. Referral of the adolescent to the Minneapolis metro area participating sites. 2. Both the parent and teen consent to participate. Exclusion Criteria: 1. Current developmental disorder or learning disorder. 2. current or past history of psychosis, or any psychiatric or other condition that may interfere with ongoing participation in the intervention. 3. Suicidal ideation or otherwise judged to be at risk to self or others 4. Unstable or uncontrolled medical illnesses which may interfere with participation in the study. 5. Inability to understand the study procedures or otherwise give informed assent for participation. 6. Failure by the parent to give informed consent for the adolescent. |
Country | Name | City | State |
---|---|---|---|
United States | University of Minnesota Medical School, Department of Psychiatry | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Treatment Research Institute | National Institute on Drug Abuse (NIDA), University of Minnesota |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adolescent Substance Use | Adolescent participants will complete the Timeline Follow Back in order to assess days of drug use. | Changes from Baseline at 3-, 6-, and 12- months post-baseline | |
Primary | Adolescent Drug Use Consequences | The adolescent participant will complete the Personal Consequences Scale in order to measure their drug use consequences. | Changes from Baseline at 3-, 6-, and 12- months post-baseline | |
Primary | DSM-IV Substance Use Diagnosis | The Adolescent Diagnostic Interview (ADI) will be used to determine a diagnosis. | Changes from Baseline at 3-, 6-, and 12- months post-baseline | |
Secondary | Adolescent Mental Health | Adolescent mental health will be measured in two ways. The parent participant will complete the ADI-Parent version and the adolescent participant will complete the Comprehensive Adolescent Severity Inventory (CASI). | Baseline and 3-, 6-, and 12- months post-baseline | |
Secondary | Adolescent Treatment History | Parent participants will provide this data when completing the ADI-Parent version. | Baseline and 3-, 6-, and 12- months post-baseline | |
Secondary | Program Acceptability | The Credibility/Expectancy Questionnaire (CEQ) will be completed by parents during the training session and the Working Alliance Inventory (WAI) will be completed my the parent after he or she completes the third training session with the adolescent. | Parent Training (average of 2 weeks post-baseline) and Post-Session 3 (average of 6 weeks after the parent training) | |
Secondary | Program Satisfaction | Parents will complete a satisfaction questionnaire after completing the third session with the adolescent participant. | Post-Session 3 (average of 6 weeks after the parent training) | |
Secondary | Training Fidelity | A training fidelity checklist will be completed by an assessor following the training. | Parent Training (average of 2 weeks post-baseline) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054738 -
CRP and S&A for Inpatient Veterans
|
N/A | |
Recruiting |
NCT04157062 -
An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder
|
N/A | |
Completed |
NCT02233738 -
Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services
|
N/A | |
Enrolling by invitation |
NCT06084221 -
Fatal Overdose Review Teams - Research to Enhance Surveillance Systems
|
N/A | |
Completed |
NCT02907944 -
Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation
|
N/A | |
Completed |
NCT02570360 -
Exercise and Treatment-as-usual in Substance Use Treatment Outcomes
|
N/A | |
Completed |
NCT02829970 -
Helping College Students With ADHD Lead Healthier Lifestyles
|
N/A | |
Completed |
NCT02715557 -
Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers
|
N/A | |
Completed |
NCT02945371 -
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
|
N/A | |
Completed |
NCT02125539 -
Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment
|
Phase 2 | |
Completed |
NCT02388243 -
The Computer-based Drug and Alcohol Training Assessment in Kenya
|
N/A | |
Completed |
NCT01633138 -
Performance-based Reinforcement to Enhance Cognitive Remediation Therapy
|
N/A | |
Completed |
NCT02218970 -
The Effect of Muscular Strength Training in Patients With Drug Addiction
|
N/A | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Withdrawn |
NCT01224002 -
A Comparative Feasibility Study to Assess the Prevalence and Severity of Dental Caries in Incarcerated People Who Abuse Methamphetamine
|
N/A | |
Withdrawn |
NCT00891631 -
Primary Care iSBIRT to Reduce Serious Teen Health Risks
|
Phase 1/Phase 2 | |
Completed |
NCT00970372 -
Dual-Diagnosis and Compulsory Treatment
|
N/A | |
Completed |
NCT01365247 -
Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT00419029 -
Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment
|
N/A | |
Completed |
NCT00317460 -
Buprenorphine and Integrated HIV Care
|
Phase 4 |